Form 13-F position report

CHINA PHARMA HLDGS INC

Reported by SABBY MANAGEMENT LLC

CPHI CUSIP 16941T401 Manager CIK 0001535610

First reported at 308,360 shares this quarter.

New
% of reported 13F value 2.25% This manager · Q3 2026
Shares 308,360 Quarter-end amount reported
Reported value $202,593 Fair value at quarter end
Consecutive quarters held 1 Through Q3 2026

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2026-09-30 202593

Quarterly position history

How this manager's reported quarter-end position changed over time.

1 quarter
Quarterly reported position history for CHINA PHARMA HLDGS INC held by SABBY MANAGEMENT LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2026 New 308,360 +308,360 (0.0%) 2.25% $202,593 2026-11-13

Who else reported the position

12 managers reported CHINA PHARMA HLDGS INC for Q3 2026.

Managers reporting CHINA PHARMA HLDGS INC in Q3 2026.
Manager Activity Shares Change % of reported 13F Reported value Tenure
SABBY MANAGEMENT LLC This report New 308,360 +308,360 2.25% $202,593 1 qtr
JANE STREET GROUP LLC Added 35,479 +21,593 < 0.01% $23,310 2 qtrs
Virtu Financial LLC New 24,129 +24,129 < 0.01% $16,000 1 qtr
StoneX Group Inc New 16,304 +16,304 < 0.01% $13,642 1 qtr
XTX Topco Ltd New 12,466 +12,466 < 0.01% $8,190 1 qtr
UBS Group AG Added 7,465 +4,356 < 0.01% $4,905 6 qtrs
Citigroup Inc New 4,314 +4,314 < 0.01% $2,834 3 qtrs
Ground Swell Capital LLC Reduced 0 -10,610 0 $0 2 qtrs
EFG International AG Reduced 0 -40 0 $0 4 qtrs
RENAISSANCE TECHNOLOGIES LLC Reduced 0 -15,045 0 $0 5 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2026
Filed
November 13, 2026
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
0
Shared
308,360
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.